Corient Private Wealth’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$621K Buy
+6,275
New +$756K ﹤0.01% 2324

Other funds holding ABVX

Corient Private Wealth's ABVX Position: Q3 2026 in Review

Corient Private Wealth opened a new position in Abivax (ABVX) in Q3 2026: 6,275 shares worth $621K. The stake represents ﹤0.01% of the portfolio and ranks #2324 among its holdings.

319 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • Corient Private Wealth held 6,275 shares of Abivax worth $621K as of Q3 2026.
  • Abivax was a new Corient Private Wealth position in Q3 2026.
  • Abivax made up ﹤0.01% of Corient Private Wealth's portfolio in Q3 2026, its #2324 holding.
  • 319 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on Corient Private Wealth's 13F filing for Q3 2026, filed 16 Nov 2026.